Skip to main content
Retour
Watch Compare

GRI Bio, Inc.

Qualité des données : 83%
GRI
NASDAQ Manufacturing Chemicals
2,49 €
▲ 0,02 € (0,81%)
6 months return
—
Momentum
Neutral
ROE
-449,90%

Croissance

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Qualité

Return on Equity
-449,90%
En dessous de la moyenne du secteur (-54,47%)
ROIC-351,15%
Net MarginN/A
Op. MarginN/A

Sécurité

Debt / Equity
N/A
Current Ratio1,70
Interest CoverageN/A

Valorisation

PE (TTM|NTM)
-0,29 | -0,31
Au-dessus de la moyenne du secteur (-1,50)
P/B Ratio1,71
EV/EBITDAN/A
Dividend YieldN/A

Quick Summary

Key Takeaways

Short bullets derived from reported financials—not the AI summary above.

Negative free cash flow of -10,19 M

Price History

Tendances Financières

Objectif de Cours des Analystes

2 analystes
Buy
+6325.7%
upside to target
Actuel
2,49 €
Consensus Target
160,00 €
40,00 €
Bas
280,00 €
Haut
Prévisions
P/E Prévisionnel
-0,31
BPA Prévisionnel
-8,03 €
CA Est.
0,0

Surprises de Résultats

EPS
Reported Estimate Forecast
Next: Q1 2026 · EPS Est: -3,74 € · Rev Est: 0,0
Q12025 Q22025 Q32025 Q42025 Q1 '26 Q2 '26
Reported -162,40 € -36,68 € -35,84 € -116,61 € — —
Estimate -105,98 € -36,68 € -31,08 € -29,26 € -3,74 € -3,72 €
Surprise -53,24% 0,00% -15,32% -298,53% — —

Growth

Rev 5Y: N/A · Earnings 1Y: N/A
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A

Profitability

ROE: -449,90% · Net Margin: N/A
Revenue (TTM) N/A Net Income (TTM) -11,96 M
ROE -449,90% ROA -228,67%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -10,19 M
ROIC -351,15% FCF Growth (3Y) N/A

Safety

D/E: N/A · Current: 1,70
Debt / Equity N/A Current Ratio 1,70
Interest Coverage N/A Asset Turnover N/A
Working Capital 1,94 M Tangible Book Value 1,99 M

Dividends

Yield: N/A · Payout: N/A
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A

Valuation

P/E: -0,29 · EV/EBITDA: N/A
P/E Ratio -0,29 Forward P/E -0,31
P/B Ratio 1,71 P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -298,77%
Market Cap 3,41 M Enterprise Value -644 732,0

Per Share

EPS: -121,80 · FCF/Share: -7,05
EPS (Diluted TTM) -121,80 Revenue / Share N/A
FCF / Share -7,05 OCF / Share -7,05
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A

Efficiency

FCF Conv: 85,22% · CapEx/Rev: N/A
CapEx / Revenue N/A FCF Conversion 85,22%
SBC-Adj. FCF -10,95 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue — — — — 0,0
Net Income -11,96 M -8,21 M -13,04 M -7,02 M -9,30 M
EPS (Diluted) -121,80 -55,21 -28,25 -0,69 -1,42
Gross Profit — — — — —
Operating Income -11,98 M -8,24 M -11,39 M -6,93 M -9,26 M
EBITDA — — — — —
R&D Expenses 6,82 M 3,77 M 3,23 M 1,17 M 5,19 M
SG&A Expenses — — — — —
D&A — — — — —
Interest Expense — — — — —
Income Tax 3 000,0 — — — —

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 8,67 M 5,74 M 2,96 M 4,15 M 8,34 M
Total Liabilities 2,66 M 1,71 M 2,70 M 1,81 M 2,52 M
Shareholders' Equity 6,01 M 4,03 M 259 000,0 2,34 M 5,82 M
Total Debt — — — — —
Cash & Equivalents 8,23 M 5,03 M 1,81 M 3,78 M 3,70 M
Current Assets 8,59 M 5,62 M 2,93 M 4,15 M 8,13 M
Current Liabilities 2,64 M 1,64 M 2,70 M 1,81 M 2,45 M

Comparaison Sectorielle

vs médiane du secteur Manufacturing (1605 pairs)
Métrique Action Médiane du Secteur
P/E -0,3 -1,5
P/B 1,7 1,6
ROE % -449,9 -54,5
Net Margin % — -41,5
Rev Growth 5Y % — 1,8
D/E — 0,3

ETFs Holding This Stock
SREAX SREAX
0,80% weight
PUREX PUREX
0,49% weight
PURGX PURGX
0,49% weight
PGRQX PGRQX
0,49% weight
PURRX PURRX
0,49% weight
PURCX PURCX
0,49% weight
DGBCX DGBCX
0,45% weight
DRLIX DRLIX
0,45% weight
DRLYX DRLYX
0,45% weight
DRLAX DRLAX
0,45% weight